Standout Papers

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from tw... 2015 2026 2018 2022 812
  1. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials (2015)
    Mario Castro, James Zangrilli et al. The Lancet Respiratory Medicine

Immediate Impact

3 by Nobel laureates 2 from Science/Nature 61 standout
Sub-graph 1 of 22

Citing Papers

Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
2025 Standout
Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis
2024 Standout
3 intermediate papers

Works of Christopher O’Brien being referenced

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
2015 Standout

Author Peers

Author Last Decade Papers Cites
Christopher O’Brien 904 836 472 778 68 2.7k
Claire O’Brien 557 630 447 397 136 5.2k
Duncan A. Robertson 108 459 645 271 67 2.4k
Jung Young Lee 215 205 344 74 87 2.5k
Moshe Leshno 298 755 1088 329 150 4.1k
John Liu 60 285 664 380 117 4.5k
Richard W. Selby 777 458 576 241 61 2.8k
Frank Heller 53 739 926 211 79 4.9k
Yong‐Mi Kim 80 363 223 109 159 4.8k
Andrea Buda 219 781 733 503 109 3.4k
William G. Murphy 85 182 357 193 100 3.3k

All Works

Loading papers...

Rankless by CCL
2026